<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
     >
    <channel>
        <title>Oligonucleotide Therapeutics Society - Feed</title>
        <atom:link href="https://oligotherapeutics.org/?feed=job_feed&#038;job_type=contract&#038;sh_atts=display_per_page:yes%7Cjob_alerts_top:no%7Cjob_alerts_bottom:no%7Cfeatured_only:no%7Cjob_alerts:no%7Cjob_custom_fields_switch:no%7Cquick_apply_job:off%7Cjob_deadline_switch:no%7Cjob_filters:no%7Cjob_filters_count:no%7Cjob_filters_sortby:default%7Cjob_filters_keyword:no%7Cjob_filters_loc:no%7Cjob_filters_loc_collapse:no%7Cjob_filters_loc_view:checkboxes%7Cjob_filters_date:no%7Cjob_filters_date_collapse:no%7Cjob_filters_type:no%7Cjob_filters_type_collapse:no%7Cjob_filters_sector:no%7Cjob_filters_sector_collapse:no%7Cjob_top_map:no%7Cjob_top_map_height:450%7Cjob_top_map_zoom:8%7Cjob_feat_jobs_top:no%7Cnum_of_feat_jobs:5%7Cjob_top_search:no%7Cjob_top_search_view:simple%7Ctop_search_title:no%7Ctop_search_location:no%7Ctop_search_sector:no%7Ctop_search_autofill:no%7Cjob_sort_by:yes%7Cjob_rss_feed:yes%7Cjobs_emp_base:no%7Cjob_excerpt:20%7Cjob_order:DESC%7Cjob_orderby:ID%7Cjob_pagination:no%7Cjob_per_page:5%7Cjob_view:view-default%7Cjob_title_len:0" rel="self" type="application/rss+xml" />
        <link>https://oligotherapeutics.org/</link>
        <description>Oligonucleotide Therapeutics Society</description>
        <lastBuildDate>Tue, 09 Jun 2026 13:00:43 +0000</lastBuildDate>
        <language></language>
        <sy:updatePeriod>hourly</sy:updatePeriod>
        <sy:updateFrequency>1</sy:updateFrequency>
        <generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://oligotherapeutics.org/wp-content/uploads/2022/05/cropped-512x512-1-1-32x32.webp</url>
	<title>Oligonucleotide Therapeutics Society</title>
	<link>https://oligotherapeutics.org/</link>
	<width>32</width>
	<height>32</height>
</image> 
                        <item>
                    <RecuiterJobNumber><![CDATA[113753]]></RecuiterJobNumber>
                    <title><![CDATA[Funded Postdoctoral Fellowship]]></title>
                    <link><![CDATA[https://oligotherapeutics.org/job/funded-postdoctoral-fellowship/]]></link>
                    <PostDate>Mon, 11 May 2026 14:56:41 +0000</PostDate>
                    <expiryDate>Fri, 10 Jul 2026 14:57:04 +0000</expiryDate>
                                            <applicationDeadline>Mon, 15 Jun 2026 00:00:00 +0000</applicationDeadline>
                                            <featured><![CDATA[no]]></featured>
                                        <employer><![CDATA[Université Grenoble Alpes]]></employer>
                    <employerImg><![CDATA[https://oligotherapeutics.org/wp-content/uploads/2022/02/no-image-150x150.webp]]></employerImg>
                                            <location><![CDATA[France, Grenoble, 38100]]></location>
                                                <sector><![CDATA[Postdoctoral Scholar]]></sector>
                                                <type><![CDATA[Contract]]></type>
                                            <excerpt><![CDATA[<p>Protection of DNA Nanostructures against Nuclease Degradation (ShielDNA) Location: Université Grenoble Alpes, Department of Molecular Chemistry (DCM) and Department of Molecular Pharmacochemistry (DPM) Supervision: Dr. Quentin Laurent (DCM) and Prof. Éric Peyrin (DPM) Duration: 2 years; Start date: Sept. 1st, 2026 The project: The field of DNA nanotechnology, taking advantage of the programmable base pairing  ...</p>
<p>The post <a href="https://oligotherapeutics.org/job/funded-postdoctoral-fellowship/">Funded Postdoctoral Fellowship</a> appeared first on <a href="https://oligotherapeutics.org">Oligonucleotide Therapeutics Society</a>.</p>
]]></excerpt>
                    <description><![CDATA[<p class="p1"><b>Protection of DNA Nanostructures against </b><b>Nuclease Degradation (ShielDNA)</b></p>
<p class="p1"><b>Location</b>: Université Grenoble Alpes, Department of Molecular Chemistry (DCM) and Department of Molecular Pharmacochemistry (DPM)</p>
<p class="p1"><b>Supervision</b>: Dr. Quentin Laurent (DCM) and Prof. Éric Peyrin (DPM)</p>
<p class="p1"><b>Duration</b>: 2 years; <b>Start date</b>: Sept. 1<span class="s1">st</span>, 2026</p>
<p class="p1"><span class="s1"><b>The project</b>: </span>The field of DNA nanotechnology, taking advantage of the programmable base pairing of DNA, has known great success in the past decades to organize matter at the nanoscale. Multiple applications arose of DNA nanostructures in biology to manipulate or interact with cells with unrivaled precision, but this has been hampered by the low stability of DNA in biological conditions, especially because of its digestion by enzymes called nucleases. <b>ShielDNA</b> aims at creating different inhibitors of nucleases by CE-SELEX (Capillary Electrophoresis Systematic Evolution of Ligands by EXponential enrichment), and at using them in conjunction with DNA nanostructures to protect them from degradation.</p>
<p class="p1"><span class="s1"><b>The position</b>: </span>The work will be shared between the two host laboratories (DCM and DPM). The recruited postdoctoral fellow will synthesize structured oligonucleotide libraries in the DCM and perform selection by CE-SELEX against various nucleases in the DPM. The creation of multiple DNA nanostructures of different morphologies, their decoration with the selected inhibitors, and their stabilization will be studied in the DCM. The work will consist in a combination of oligonucleotide synthesis and self-assembly on one side, and on directed evolution and preliminary biological evaluations on the other.</p>
<p class="p1"><b>The candidate</b>:</p>
<p class="p2"><span class="s1">o</span> You are curious, research-driven and rigorous in your work, with good communication skills. You show initiative and creative thinking and are a team player.</p>
<p class="p2"><span class="s1">o</span> You have experience in the fields of oligonucleotide, directed evolution by SELEX and/or supramolecular chemistry, and a good scientific track record.</p>
<p class="p2"><span class="s1">o</span> Previous experience in DNA nanotechnology will be greatly appreciated but is not mandatory.</p>
<p class="p2"><span class="s1">o</span> You must hold a PhD degree.</p>
<p class="p3"><span class="s3"><b>How to apply</b>: </span><span class="s4">An email should be addressed to </span>quentin.laurent1@univ-grenoble-alpes.fr<span class="s4"> and </span><span class="s5">eric.peyrin@univ-grenoble-alpes.fr</span> with “Postdoctoral Fellowship Application ShielDNA” as the subject. Applications should include a single PDF file containing a detailed CV including a list of publications, a short research summary, a cover letter, a proof of obtention of the PhD diploma and the contact of at least two references you worked with. Successful candidates will be invited to an online interview.</p>
<p class="p1"><b>The DCM and DPM laboratories</b> <span class="s1">are composed of 5 and 2 </span>teams respectively, covering most aspects of molecular chemistry, and fully equipped to handle synthesis, selection and characterizations of DNA nanostructures.</p>
<p class="p2">Grenoble is the capital of the French Alps, located 1 h away from Lyon. Nested in the middle of the mountains, it offers a high quality of life for one who loves nature.</p>
]]></description>
                                                        </item>
                    </channel>
</rss>